Nuacht

The US FDA has approved Element Science’s premarket approval (PMA) application for its Jewel Patch Wearable Cardioverter ...
Neurogen Biomarking has announced a collaboration with NeuroX to support patients’ journey on its brain health care ecosystem ...
Health technology company Resmed has acquired the software-enabled independent diagnostic testing facility (IDTF), VirtuOx.
The US Food and Drug Administration (FDA) has cleared OcuSciences’ retinal health assessment device, the OcuMet Beacon.
HeartBeam’s synthesised 12-lead ECG has met the clinical endpoints in the VALID-ECG pivotal study, assessing ...
LuxIA, an AI algorithm co-developed by RetinAI US and FVS, has achieved CE-MDR certification for diabetic retinopathy (DR) ...
Canada’s UHN and U of T researchers have created a skin-based test that identifies progressive supranuclear palsy (PSP) ...
A baby has been born following an AI-automated in vitro fertilisation (IVF) procedure conducted remotely by engineers and ...
GE HealthCare is expecting its 2025 revenues to take a hit of around $500m due to the Trump administration’s imposition of ...
The FDA has approved Edwards Lifesciences' SAPIEN 3 TAVR platform for the treatment of patients with asymptomatic severe ...
The London Cancer Hub has been identified as a key district for ‘frontier innovation’ by London Mayor Sadiq Khan.
SafeHeal has pulled in €35m ($39.7m) in Series C equity financing to validate its Colovac endoluminal bypass system.